Analyst Ratings for Ligand Pharmaceuticals Inc. (LGND)

Updated: 2017-07-28

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was awarded an average rating of Buy from investment analysts following the stock. LGND had previously received a consensus rating of Buy a month ago.

4 analysts declared LGND a buy, 0 gave an overweight rating, 1 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for LGND. The most optimistic price target was 160, implying potential capital gains of 31.95 percent. The minimum price target given was 103, implying potential capital losses of -15.06 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 5.46 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -21.71 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.73 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -5.94 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

LGND has a 52-week high of 139.79 and a 52-week low of 87.50. Currently the stock is 38.58 percent higher than its low, and below the high by 13.26 percent. LGND has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The LGND value stock report compares LGND to some of its peers using value stock charts. The market cap of LGND is $2.54 billion. LGND's next earnings release will be on 0000-00-00, which is days away.